The SARS-CoV-2 envelope protein disrupts barrier function in an in vitro human blood-brain barrier model
Authors:
Open Access
- 23 August 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 16, 897564
Abstract
Patients with coronavirus disease 2019 (COVID-19) have been frequently reported to exhibit neurological manifestations and disruption of the blood-brain barrier (BBB). Among the risk factors for BBB breakdown, the loss of endothelial cells and pericytes has caused widespread concern. Recent studies have revealed that severe acute respiratory syndrome coronavirus 2 envelope (S2E) protein caused cell death. We tested the hypothesis that the S2E protein alone could induce BBB dysfunction. The S2E protein bound to human BBB-related cells and inhibited cell viability in a dose- and time-dependent manner. Importantly, the S2E protein disrupted barrier function in an in vitro BBB model composed of HCMEC/D3 (brain endothelial cell line), HBVP (brain vascular pericyte), and U87MG (astrocyte cell line) cells and suppressed the expression of major genes involved in maintaining endothelial permeability and function. In addition, the S2E protein crossed the HCMEC/D3 monolayer. The S2E protein triggered inflammatory responses in HCMEC/D3 and U87MG cells. Taken together, these results show for the first time that the S2E protein has a negative impact on the BBB. Therapies targeting the S2E protein could protect against and treat central nervous system manifestations in COVID-19 patients.Keywords
Funding Information
- National Natural Science Foundation of China (81930104, 82071504, 82101545)
This publication has 56 references indexed in Scilit:
- Epithelial barrier assembly requires coordinated activity of multiple domains of the tight junction protein ZO-1Journal of Cell Science, 2013
- Development of a three-dimensional, all-human in vitro model of the blood–brain barrier using mono-, co-, and tri-cultivation Transwell modelsJournal of Neuroscience Methods, 2011
- Glatiramer Acetate Treatment Increases Stability of Spinal Synapses and Down Regulates MHC I during the Course of EAEInternational Journal of Biological Sciences, 2011
- The SARS Coronavirus E Protein Interacts with PALS1 and Alters Tight Junction Formation and Epithelial MorphogenesisMolecular Biology of the Cell, 2010
- Major histocompatability complex class I expression and glial reaction influence spinal motoneuron synaptic plasticity during the course of experimental autoimmune encephalomyelitisJournal of Comparative Neurology, 2009
- Pyroptosis: host cell death and inflammationNature Reviews Microbiology, 2009
- ZOning out Tight JunctionsCell, 2006
- A role for MHC class I molecules in synaptic plasticity and regeneration of neurons after axotomyProceedings of the National Academy of Sciences, 2004
- Hydrogen peroxide-induced alterations of tight junction proteins in bovine brain microvascular endothelial cellsMicrovascular Research, 2004
- Tight junctions of the blood–brain barrierVascular Pharmacology, 2002